Apotex Subsidiary Signa Gets FDA Warning Letter

Signa, a Mexican subsidiary of Canadian generic drugmaker Apotex, has received an FDA warning letter for failure to correct manufacturing problems for active pharmaceutical ingredients (API) that were later released into the U.S. market.
Source: Drug Industry Daily